Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER
| Status: | Completed |
|---|---|
| Conditions: | Cardiology, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/6/2019 |
| Start Date: | September 2003 |
| End Date: | September 2010 |
The purpose of this feasibility study is to investigate the safety of the AMPLATZER®
Membranous VSD Occluder for the treatment of hemodynamically significant Perimembranous
Ventricular Septal Defects.
Membranous VSD Occluder for the treatment of hemodynamically significant Perimembranous
Ventricular Septal Defects.
Inclusion Criteria:
- Patients with hemodynamically significant Perimembranous ventricular septal defects
Exclusion Criteria:
- Patients < 8 kg
- Supracristal ventricular septal defects
- Left ventricle to right atrium shunting
- Prolapse of the aortic valve
- Right to left shunting through the defect
- Perimembranous VSD with an aneurysm and multiple shunts which can not be successfully
closed with one device
- Patients with <2mm aortic rim
- Sepsis (local/generalized)
- Complex heart lesions such as atrioventricular canal defect or Tetralogy of Fallot.
- Patients who are ASA intolerant
- Unable to be followed for the duration of the clinical trial
- Inability to obtain informed consent
We found this trial at
6
sites
171 Ashley Avenue
Charleston, South Carolina 29425
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
Click here to add this to my saved trials
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials
Columbia University In 1897, the university moved from Forty-ninth Street and Madison Avenue, where it...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials